Two new coumestan glycosides, coumestoside C (1) and coumestoside D (2), were isolated from the stem bark of Cylicodiscus gabunensis Harms. Their structures were established by spectroscopic means and chemical transformations as 9-O-α-Lrhamnopyranosyl-3-hydroxy-4-(5′-hydroxy-3′-methylbut-2′E-enyl) coumestan (1) and 9-O-β-D-galactopyranosyl-3-O-prenyl-4-hydroxycoumestan. Coumestoside C exhibited antimicrobial activity against Proteus vulgaris.
Stem bark of Cylicodiscus gabunensis Harms (Mimosaceae) is used to prepare remedies for infectious diseases [1a] , and is known for its antimicrobial and antiplasmodial activities [1b] . Previous phytochemical investigations of C. gabunensis have led to the isolation of triterpenoid saponins and coumestans [1b], the latter being a class of compounds known to exert a variety of biological activities [1c-1e]. In the present communication, we report the structure elucidation of two new flavonoid derivatives, coumestoside C (1) and coumestoside D (2) , isolated from the same species.
Compound 1, coumestoside C, was obtained as a white powder. The HRMS showed a molecular ion peak at m/z = 498.1517 consistent with the molecular formula C 26 H 26 O 10 . The IR spectrum of 1 disclosed absorptions due to a δ-lactone carbonyl (1725 cm -1 ), aromatic ring (1625, 1604, 1500 cm -1 ) and aromatic C-O (1222 cm -1 ), as well as UV absorption maxima at 246, 315 and 353 nm, indicating the presence of a coumestan skeleton [1b,1f,2]. Furthermore, absorption bands at 3410-3200 cm -1 and the positive response to the FeCl 3 color test indicated the presence of hydroxyl groups. Peracetylation of compound 1 afforded a penta-acetate derivative (1a), whose molecular formula, C 36 . Based on the HMBC spectrum, which showed correlation between H-1′ (δ 3.15) and C-4 (δ 109.1), this substituent was located at C-4.
The 13 C and 1 H NMR spectra of 1 resembled those of other coumestan glycosides [1b]. Acid hydrolysis with 2N HCl produced a sugar component and an aglycone. The sugar was identified by GLC analysis of its TMSi derivative as L-rhamnose. Correlation observed in the HMBC spectrum between H-1″ (δ 4.26) and C-9 (δ 160.1) indicated that the sugar moiety was bound to C-9. The α-configuration of the L-rhamnopyranosyl moiety was deduced from the value of the coupling constant (J = 2.1 Hz) of the anomeric proton at δ 4.26 in the 1 H NMR spectrum.
According to the molecular formula, there was a second hydroxyl group in 1, which on a biogenetic basis was assumed to be at C-3 [3] . Furthermore, the 1 H and 13 C NMR data of the aglycone (Tables 1 and  2) , as well as the IR and MS evidence (see Experimental), were consistent with structure 3. Thus the structure of coumestoside C was elucidated to be 9-O-α-L-rhamnopyranosyl-3-hydroxy-4-(5′-hydroxy-3′-methyl but-2′E-enyl) coumestan. , and 5.40 (vinyl proton) were consistent with the presence of an O-prenyl substituent, which was located at C-3 on the basis of the HMBC spectrum, which showed correlation between H-1′ (δ 4.38) and C-3 (δ 153.2). The 13 C and 1 H NMR spectra of 2 resembled those of 1.
On acid hydrolysis, compound 2 yielded a sugar component, identified as D-galactose by GLC analysis of its TMSi derivative, and an aglycone. Based on the HMBC spectrum, which showed correlation between H-1″ (δ 4.32) and C-9 (δ 160.2), the sugar moiety was bound to C-9. The β configuration of the D-galactopyranosyl moiety was deduced from the value of the coupling constant (J = 7.6 Hz) of the anomeric proton at δ 4.32 in the 1 H NMR spectrum [4] . The molecular formula of 2, in addition to the positive response to the color test (FeCl 3 ), indicated the presence of one OH group (phenolic), which was located at C-4 on the basis of the above results. Furthermore, the 1 H and 13 C NMR spectroscopic data of the aglycone (Tables 1 and 2) , as well as the IR and mass spectral evidence, were consistent with structure 4. On the basis of the above evidence, the structure of coumestoside D was determined as 9-O-β-D-galactopyranosyl-3-O-prenyl-4-hydroxycoumestan. Disk diffusion assay showed that coumestoside C (1) had an antimicrobial activity against Proteus vulgaris at a concentration of 0.21 mg/disc. The inhibition zone and MIC (minimal inhibition concentration) value against this microorganism was 12.5 ± 0.5 µm and 0.005 mg/mL, respectively. 
Extraction and isolation:
Dried ground stem bark of C. gabunensis (5.4 Kg) was immersed in ethyl acetate (25 L) and kept for 72 h.The ethyl acetate extract, after concentration under reduced pressure, produced 220 g of residue. A 100 g portion of this was subjected to column chromatography on silica gel (400 g) using an eluent of n-hexane -ethyl acetate -methanol of increasing polarity. Fractions (175), each of 250 mL, were collected and combined on the basis of TLC results. Fractions 125-175 (13 g) were again chromatographed on Sephadex LH20 (250 g) using methanol as eluent. Fifty fractions, each of 200 mL, were collected and combined on the basis of TLC evidence. Fractions 22-36 (3.2 g) were again chromatographed, as described for fractions 125-175. From a total of 36 fractions, each of 75 mL, fractions 24-31 (220 mg) were further purified, using preparative TLC and MeOH/CHCl 2 /H 2 O (5/4.75/0.25) as the development solvent, to give compounds 1 (44 mg) and 2 (37.5 mg). 
